Dr. Lawrence Steinman, MD is a professor of Neurology and Neurological Sciences, Pediatrics, and Genetics at Stanford University Medical School. Dr. Steinman has received numerous honors and awards, including election to the National Academy of Sciences, and the National Academy of Medicine. He is the recipient of the John M. Dystel Prize from the American Academy of Neurology and the National MS Society for his research on MS, and the Charcot Prize for Lifetime Achievement in MS research. He is the recipient of the Cerami Prize in Translational Research. Dr. Steinman holds a number of patents in the areas of immunology, Type 1 diabetes and MS. He cofounded Neurocrine Biosciences, Bayhill Therapeutics (now named Tolerion), Nuon Therapeutics, Transparency Life Sciences and Atreca. He was a Director of Centocor from 1988 until its sale to Johnson and Johnson.